Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06479941

Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota

Based on a prospective birth cohort, the investigators will collect biological samples from participants including pregnant women and newborns, to measure the gut microbial diversity and metabolites of newborns. These results systematically evaluate the effects of antibiotic exposure on the structure and function of gut microbiota. The project can reveal the effects of antibiotic exposure on the growth and development of gut microbiota in early life.

Recruiting

Interested in participating?

Request Info

Key information

Age range

1 day–12 month

Sex eligibility

All sexes

Study type

Observational

Primary location

The Peking University People's Hospital

Beijing, China

Location status: Recruiting

Location contact

Xue Xu, Dr.

CONTACT

[email protected]

010-88324385

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant woman
  • aged 20-40 years old
  • natural conception
  • single pregnancy
  • gestational age ≥36 weeks
  • Newborn
  • normal Apgar score
  • no serious congenital diseases

Exclusion criteria

-

Treatment and study plan

antibiotic treatment

Other

AT: Mother-infant cohort with antibiotic treatment group CS: Mother-infant cohort (Prophylactic antibiotics therapy) ND: Mother-infant cohort (Natural delivery)

Primary outcomes

  1. Infant gut microbiome

    Time frame: Pregnancy (12, 24, 37 weeks) and infants (born, 1 week, and 1, 3, 6, 12 months)

    • Diversity of gut microbiota
    • Abundance of antibiotic resistance genes in gut microbiota
    • Metabolic pathway of gut microbiota

Secondary outcomes

  1. Antibiotic treatment

    Time frame: Pregnancy (12, 24, 37 weeks) and infants (born, 1 week, and 1, 3, 6, 12 months)

    • Frequency of antibiotic treatment
    • Kind and Dose of antibiotic;
    • Duration of antibiotic use;

Sponsors and collaborators

Lead sponsor

Peking University People's Hospital

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jun 28, 2024
Registry last updated
Jul 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.